Tetraphase Pharmaceuticals to Present Data at 26th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
April 07, 2016 08:00 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., April 07, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced five data presentations at the 26th European Congress of Clinical Microbiology...
Tetraphase Pharmaceuticals to Present at Needham Conference 2016
April 06, 2016 08:00 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., April 06, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat...
Tetraphase Pharmaceuticals to Present at Roth Conference 2016
March 10, 2016 09:10 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., March 10, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat...
Tetraphase Pharmaceuticals Reports Fourth-Quarter and Full-Year 2015 Financial Results and Provides Corporate Update
February 23, 2016 16:01 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., Feb. 23, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat...
Tetraphase Pharmaceuticals to Host Conference Call on February 23 to Discuss Fourth Quarter and Full Year Financial Results and Provide Corporate Update
February 19, 2016 09:14 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., Feb. 19, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
Tetraphase Pharmaceuticals Initiates Phase 1 Clinical Trial for TP-271
January 19, 2016 08:00 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., Jan. 19, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced the initiation of patient dosing in a phase 1 clinical trial for intravenous (IV)...
Tetraphase Pharmaceuticals to Present at Oppenheimer 26th Annual Healthcare Conference
December 03, 2015 09:11 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., Dec. 3, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
Tetraphase Pharmaceuticals to Provide Corporate Update at Stifel 2015 Healthcare Conference
November 12, 2015 08:00 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., Nov. 12, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
Tetraphase Pharmaceuticals Reports Third-Quarter 2015 Financial Results
November 02, 2015 07:30 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., Nov. 2, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
Eravacycline Data Supporting Activity Against Multidrug-Resistant Gram-Negative Bacteria to be Presented at IDWeek 2015
October 07, 2015 08:00 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., Oct. 7, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...